USPTO 2015–2025 USPTO PatentsView Foreign Corporation

BioApplications Inc.

USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bioapplications ranks #18,438 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.

#18,438
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.6/100)
11.7
avg claims per patent
+400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18438 · Foreign Corporation #18,438 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,438/49,997
  • PHOTO-FINISH Bellicon
  • CPC-NARROW C12N · 7 areas
  • INNOV-THIN 37.6/100
  • CLAIMS-PAR 11.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +400% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bellicon AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bioapplications’s 37.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bioapplications

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bioapplications's Innovation Score is 37.6/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bioapplications?

Each dot is one of Bioapplications’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioapplications’s own 11.7 claims/patent is ABOVE the 8.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bioapplications vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 0102030 Granted patents (volume) Avg claims / patent Bellicon AG - 15, 4.13BelliconBenson Hill, Inc. - 15, 12.8Benson HillBest Brands Consumer Products, Inc. - 15, 2.4Best Brands Consu…Binggrae Co., Ltd. - 15, 1BinggraeBioLite, Inc. - 15, 8.6BioliteBiological E Limited - 15, 11.2Biological EBitstrata Systems Inc. - 15, 25.2Bitstrata SystemsBittium Biosignals Oy - 15, 13.93Bittium Biosignal…BioApplications Inc. - 15, 11.67Bioapplications
Bioapplications vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bioapplications's grants concentrate

BioApplications Inc. is a focused PatentsView assignee: 7 CPC subclasses with 93.3% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2016. By volume, Bioapplications sits between Bellicon AG and Bittium Biosignals Oy.

Bioapplications's three-year grant acceleration

BioApplications Inc. shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at BioApplications's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows BioApplications holds 15 patents at rank #18,447, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near BioApplications

By rank, the assignees closest to #18,447 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in BioApplications's primary technology class.

Bioapplications's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20162019202020212022202320242025 3
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
BioApplications Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 6.7%
2019 1 6.7%
2020 1 6.7%
2021 2 13.3%
2022 3 20.0%
2023 1 6.7%
2024 3 20.0%
2025partial year 3 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

BioApplications Inc.'s patent record in context - here's where to go next.

  • BioApplications Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 93.3% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #18,438 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare BioApplications Inc. against Bellicon AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.